High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 21, 2024

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Vonoprazan

Potassium competitive acid blocker

DRUG

Amoxicillin

Antibiotics for H. pylori eradication

DRUG

Bismuth Potassium Citrate

Gastric mucosal protective drug with anti-H. pylori effect

DRUG

Minocycline,Metronidazole

Antibiotics for H. pylori eradication

Trial Locations (10)

200127

RECRUITING

Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai

Unknown

RECRUITING

Hebi People's Hospital, Hebi

RECRUITING

Jiaozuo People's Hospital, Jiaozuo

RECRUITING

Luoyang central Hospital, Luoyang

RECRUITING

The first people's hospital of ping ding shan, Pingdingshan

RECRUITING

Xuchang central Hospital, Xuchang

RECRUITING

The Second Affiliated Hospital of Henan University of science and technology, Zhengzhou

RECRUITING

The Third People's Hospital of Zhengzhou, Zhengzhou

RECRUITING

Zhengzhou People's Hospital, Zhengzhou

RECRUITING

Zhoukou Central Hospital, Zhoukou

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER